Home
Conditions
Adenocarcinoma

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,027 public trials 1,169 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Recruiting

Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NEN

NCT06735560

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +16 more
Locations: CHU de Nantes Nantes, France

AP-HP - Site de Beaujon Paris, France

View Trial Details

Recruiting

FOLFOX Combined With Durvalumab (MEDI4736), Bevacizumab, and Stereotactic Body Radiotherapy in Sequential Treatment of Potentially Resectable Locally Advanced Hepatocellular Carcinoma

NCT07012798

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Tianjin Cancer Hospital Airport Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma

NCT06058663

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +8 more
Locations: Mayo Clinic in Florida Jacksonville, Florida, United States

View Trial Details

Recruiting

CD70-targeted immunoPET Imaging of Malignant Cancers

NCT06852638

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +37 more
Locations: Renji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai, China

View Trial Details

Recruiting

Epirubicin Interventional Chemotherapy for Sinonasal Adenoid Cystic Carcinoma (SNACC): A Prospective Study

NCT07320508

Conditions: Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +6 more
Locations: Eye and ENT Hospital, Fudan University Shanghai, Xuhui Strict, China

View Trial Details

Recruiting

Tislelizumab Combined With Huaier Granule as First-line Treatment for Unresectable Hepatocellular Carcinoma

NCT07413354

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, No. 1095, Jiefang Avenue, Wuhan 430030, Hubei, China Wuhan, Hubei, China

View Trial Details

Recruiting

Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell Carcinoma

NCT07571551

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University Nanjing, Jiangsu, China

View Trial Details

Recruiting

Computer Guided Microwave Liver Ablation

NCT07226869

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dartmouth HItchcock Medical Center Lebanon, New Hampshire, United States

View Trial Details

Recruiting

The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine

NCT07150624

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Anhui Provincial Hospital Hefei, Anhui, China

View Trial Details

Recruiting

A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement

NCT06728410

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +6 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Adenocarcinoma

Adenocarcinoma trial results

Related conditions